Pneumocystis jirovecii pneumonia in liver transplant recipients: a systematic review

I D Kostakis1, G C Sotiropoulos1, G Kouraklis1

  • 1Second Department of Propedeutic Surgery, "Laiko" General Hospital, National and Kapodistrian University of Athens, Medical School, Athens, Greece.

Transplantation Proceedings
|November 26, 2014
PubMed
Abstract

Insights

Prophylactic trimethoprim-sulfamethoxazole significantly reduces the incidence and mortality of Pneumocystis jirovecii pneumonia (PJP) in liver transplant recipients. Extended use for one year post-transplant is recommended to prevent this opportunistic infection.

Area of Science:

  • Infectious Diseases
  • Transplant Surgery
  • Mycology

Background:

  • Pneumocystis jirovecii causes pneumonia in immunocompromised individuals.
  • Liver transplant recipients are particularly susceptible to P. jirovecii infections.

Purpose of the Study:

  • To review the incidence and outcomes of P. jirovecii pneumonia (PJP) in liver transplant recipients.
  • To evaluate the effectiveness of prophylactic treatment for PJP in this patient population.

Main Methods:

  • A systematic literature search was conducted using Medline.
  • Keywords included "liver transplantation" and "pneumocystis."
  • 35 relevant articles were selected for review from 60 initial results.

Main Results:

  • PJP incidence in liver transplant recipients without prophylaxis ranges from 1% to 11%, with mortality rates between 7% and 88%.
  • Most PJP cases occur within 7 months post-transplantation.
  • Prophylaxis with oral trimethoprim-sulfamethoxazole reduces PJP incidence to 0%-3%.

Conclusions:

  • PJP poses a significant risk of high incidence and mortality in liver transplant recipients without prophylaxis.
  • Oral trimethoprim-sulfamethoxazole prophylaxis is highly effective in preventing PJP.
  • Prophylaxis should be administered for one year following liver transplantation.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...